When his lymphoma stopped responding to standard therapy, Alex turned to a form of immunotherapy known as CAR T-cell therapy.
Read Alex's Story
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreWhen she was diagnosed with a rare type of cancer called epithelioid sarcoma, Sandra Griego turned to a cancer clinical trial as her best option.
Read Sandra’s StoryEwing sarcoma is a rare type of cancer with an incidence that is nine times greater in Caucasians than in African Americans. July is Sarcoma Awareness Month.
Learn MoreKevan M. Shokat, PhD, spearheaded a paradigm-shifting solution to the decades-long puzzle of targeting the KRAS protein to open new opportunities to target lung cancer and many other malignancies.
Read AACR StoriesWhat are some red flags for consumers looking to save money by purchasing medications from online pharmacies? Read this and other articles from Cancer Today magazine.
Read Practical KnowledgeWhether honoring a special person or a special day, a donation to the American Association for Cancer Research (AACR) has a lasting impact.
Donate NowRegister by September 22 to get the lowest rates for the symposium (December 5-9).
The AACR Cancer Progress Report 2022 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 54,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreAACR President Lisa M. Coussens, PhD, FAACR, discusses the research-driven advances against cancer and looks to the future of cancer science and medicine.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Moretherapeutics against cancer were approved by the FDA from August 1, 2021, to July 31, 2022
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2019
Learn More